|
| Status |
Public on May 11, 2011 |
| Title |
Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
21558518, 24337596, 36293478 |
| Submission date |
Nov 01, 2010 |
| Last update date |
Nov 02, 2022 |
| Contact name |
Christos Hatzis |
| E-mail(s) |
christos@nuverabio.com
|
| Phone |
781-938-3830
|
| URL |
http://www.nuverabio.com
|
| Organization name |
Nuvera Biosciences
|
| Street address |
400 West Cummings Park, Suite 5350
|
| City |
Woburn |
| State/province |
MA |
| ZIP/Postal code |
01801 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL96 |
[HG-U133A] Affymetrix Human Genome U133A Array |
|
| Samples (508)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE25055 |
Discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| GSE25065 |
Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
|
| Relations |
| BioProject |
PRJNA134729 |
Less...
More...